Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole in Adult Patients With Hematologic Malignancy Receiving Voriconazole Treatment Due to an Invasive Fungal Infection

NCT04547335 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.

NCT NCT04547335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04547335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole in Adult Patients With Hematologic Malignancy Receiving Voriconazole Treatment Due to an Invasive Fungal Infection
Lead sponsor
Dokuz Eylul University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
October 31, 2022
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reactions